Oncology & Cancer Medicines Supply
OctaGenix is an international oncology medicines supplier specialising in the premium sourcing and reliable supply of oncology and cancer medicines, including both originator brands and high-quality generics. Through trusted pharmaceutical supply networks across the UK, EU, USA, India and Australia, OctaGenix supports complex oncology medicine procurement requirements while maintaining high standards of product quality, regulatory compliance and supply continuity.
All oncology products are supplied with Certificate of Pharmaceutical Product (CoPP) documentation, providing customers with additional assurance of authenticity, quality and compliance. OctaGenix also has specialist expertise in cancer drug procurement and oncology drug supply for orphan and ultra-orphan diseases, supporting access to treatments for rare cancers where medicine availability can be highly limited.
Our team manages the complete sourcing and supply process from product identification through to delivery, including specialist handling requirements and full cold-chain management where required. Through this international sourcing capability, OctaGenix supports access to oncology medicines across a broad range of cancer treatment pathways recognised by global health and cancer research organisations, including the World Health Organization (WHO) and Cancer Research UK
- Approved product information and labelling
- cGMP-compliant manufacturing and quality control
- Certified by global regulatory bodies including: MHRA, EMA, FDA, PMDA, TGA & CDA-AMC.
- QP details for PV
- Pharmacovigilance and post-market safety system
- Safety data
- MA Holder details
- Full Dossier (if required)
Oncology Medicine Supply for Healthcare Systems
OctaGenix supports hospitals, healthcare organisations, government bodies, procurement agencies and authorised pharmaceutical distributors with sourcing and supply enquiries across a broad portfolio of oncology medicines and cancer medicines. This includes injectable chemotherapy, oral anticancer medicines, targeted therapies, biologics, biosimilars, hormonal therapies and specialist medicines used in rare and complex cancers, subject to regulatory and commercial availability.
Other Products
Get in Contact?
Get in touch with our team to discuss product availability, procurement requirements, and how OctaGenix can support your healthcare supply needs.
| Product | Strength | Formulation |
|---|---|---|
| Amifostine | 500mg | Injection |
| Bleomycin (Lyophilized) | 15 IU | Injection |
| Carboplatin | 150mg/15ml; 450mg/45ml; 600mg/60ml | Injection |
| Cisplatin | 10mg/10ml; 50mg/50ml | Injection |
| Cyclophosphamide (Lyophilized) | 100mg; 200mg; 500mg; 1000mg | Injection |
| Cytarabine | 100mg/ml; 500mg/5ml; 1000mg/10ml | Injection |
| Dacarbazine (Lyophilized) | 200mg; 500mg; 1gm | Injection |
| Dactinomycin (Lyophilized) | 500mcg | Injection |
| Daunorubicin (Lyophilized) | 20mg | Injection |
| Di-Sodium Pamidronate (Lyophilized) | 30mg; 60mg; 90mg | Injection |
| Docetaxel (With Solvent) Cake | 20mg; 80mg; 120mg | Injection |
| Doxorubicin (Liquid) | 10mg/5ml; 50mg/25ml | Injection |
| Doxorubicin (Lyophilized) | 10mg; 50mg | Injection |
| Epirubicin (Liquid) | 10mg/5ml; 50mg/25ml; 100mg/50ml | Injection |
| Epirubicin (Lyophilized) | 10mg; 50mg | Injection |
| Etoposide | 100mg/5ml | Injection |
| Fludarabine | 50mg/2ml | Injection |
| 5-Fluorouracil | 250mg/2.5ml; 500mg/5ml | Injection |
| Gemcitabine | 200mg; 1gm; 1.4gm | Injection |
| Ifosfamide | 1gm; 2gm | Injection |
| Irinotecan | 40mg/2ml; 100mg/5ml | Injection |
| L-Asparaginase (Lyophilized) | 5000 IU; 10000 IU | Injection |
| Leuprolide | 3.75mg; 7.5mg; 11.25mg; 22.5mg | Injection |
| Mesna | 200mg/2ml; 400mg/4ml | Injection |
| Methotrexate | 7.5mg/ml; 15mg/2ml; 50mg/2ml; 100mg/4ml | Injection |
| Methylene Blue | 10mg | Injection |
| Mitomycin-C | 2mg; 5mg; 10mg; 20mg | Injection |
| Oxaliplatin (Liquid) | 50mg/25ml; 100mg/50ml | Injection |
| Oxaliplatin (Lyophilized) | 50mg; 100mg | Injection |
| Paclitaxel | 30mg/5ml; 100mg/16.6ml; 260mg/43.4ml; 300mg/50ml | Injection |
| Pamidronate (Lyophilized) | 30mg; 60mg; 90mg | Injection |
| Pemetrexed (Lyophilized) | 100mg; 500mg | Injection |
| Topotecan | 2.5mg/2.5ml; 4mg/4ml | Injection |
| Temoporfin | 1mg/ml | Injection |
| Vinblastine | 10mg/10ml | Injection |
| Vincristine | 1mg/ml; 2mg/2ml | Injection |
| Vinorelbine | 10mg/ml; 20mg/2ml; 50mg/5ml | Injection |
| Voriconazole (Lyophilized) | 200mg | Injection |
| Zoledronic Acid (Lyophilized) | 4mg | Injection |
| Daunorubicin | 20mg | Injection |
| Doxorubicin | 20mg/10ml; 50mg/25ml | Injection |
| L-asparaginase | 5000 IU; 10000 IU | Injection |
| Paclitaxel | 30mg; 100mg; 260mg; 300mg | Injection |
| Azacitidine Injection (Lyophilized) | 100mg | Injection |
| Bevacizumab Injection | 100mg; 400mg | Injection |
| Bortezomib Injection | 2mg; 3.5mg | Injection |
| Cabazitaxel Injection | 60mg/1.5ml | Injection |
| Calcium Folinate Injection / Leucovorin Calcium (Lyophilized) | 100mg | Injection |
| Melphalan Injection | 50mg | Injection |
| Paclitaxel Injection Concentrate for Nanodispersion | 300mg; 100mg | Injection |
| Paclitaxel Protein Bound Particle for Injectable Suspension (Albumin-Bound) | 100mg paclitaxel + approx. 900mg human albumin | Injection |
| Pegaspargase Injection | 3,750 IU | Injection |
| Thiotepa Injection (Lyophilized) | 15mg; 100mg | Injection |
| Trastuzumab Injection | 400mg | Injection |
| Methotrexate | 25mg/ml | Pre-filled Syringe |
| Erythropoietin | 2000; 3000; 4000; 5000; 10000; 20000; 40000 IU/ml | Pre-filled Syringe |
| Filgrastim | 300mcg/1ml | Pre-filled Syringe |
| Fulvestrant | 250mg/1ml; 500mg/1ml | Pre-filled Syringe |
| Abiraterone Acetate | 250mg; 500mg | Tablet |
| Anastrozole | 1mg | Tablet |
| Azathioprine | 50mg | Tablet |
| Capecitabine | 150mg; 500mg | Tablet |
| Chlorambucil | 20mg | Tablet |
| Cyclophosphamide | 50mg | Tablet |
| Erlotinib | 25mg; 100mg; 150mg | Tablet |
| Fludarabine Phosphate | 10mg | Tablet |
| Flutamide | 250mg | Tablet |
| Gefitinib | 250mg | Tablet |
| Imatinib | 100mg; 400mg | Tablet |
| Letrozole | 2.5mg; 5mg | Tablet |
| Mycophenolate Mofetil | 250mg; 500mg; 750mg | Tablet |
| Mycophenolate Sodium | 180mg; 360mg | Tablet |
| Tamoxifen Citrate | 10mg; 20mg; 50mg | Tablet |
| Tretinoin | 10mg; 20mg | Tablet |
| Aprepitant Kit | 125mg + 80mg | Capsule |
| Crizotinib | 250mg | Capsule |
| Cyclosporine | 25mg; 50mg; 100mg | Capsule |
| Enzalutamide | 40mg | Capsule |
| Etoposide | 50mg; 100mg | Capsule |
| Ganciclovir | 500mg | Capsule |
| Hydroxyurea | 250mg; 500mg | Capsule |
| Imatinib Mesylate | 100mg; 400mg | Capsule |
| Lenalidomide | 10mg; 15mg | Capsule |
| Lenvatinib | 10mg | Capsule |
| Palbociclib | 125mg | Capsule |
| Procarbazine | 50mg | Capsule |
| Sunitinib | 12.5mg; 25mg; 37.5mg; 50mg | Capsule |
| Tacrolimus | 0.5mg; 1mg; 5mg | Capsule |
| Temozolomide | 20mg; 100mg; 250mg | Capsule |
| Thalidomide | 50mg; 100mg; 150mg; 200mg; 300mg | Capsule |
| Nilotinib | 200mg | Capsule |
| 5-Fluorouracil Cream | 5% w/w | Topical |
FAQ
Frequently Asked Questions About Bulk Vaccine Supply
Yes. OctaGenix supports international sourcing and supply enquiries for oncology medicines through established pharmaceutical supply networks across multiple markets. Availability is assessed according to the medicine, strength, formulation, quantity, destination and applicable regulatory requirements.
OctaGenix supports enquiries across a broad range of cancer medicines, including injectable chemotherapy, oral anticancer medicines, targeted therapies, biologics, hormonal treatments, generics, biosimilars and specialist oncology products.
Yes. OctaGenix has experience in the procurement and supply of oncology medicines for orphan and ultra-orphan indications, including treatments for rare cancers where normal commercial availability may be limited.
Yes. OctaGenix supports cancer drug procurement requirements for authorised healthcare organisations, institutions, procurement bodies and pharmaceutical partners. Requirements can include product sourcing, availability assessment, documentation and supply coordination.
Available documentation may include approved product information, labelling, manufacturing and quality information, pharmacovigilance details, safety data, marketing authorisation holder information and full dossier documentation where required and available.
Where required by the individual medicine, OctaGenix can coordinate specialist handling and cold-chain requirements as part of the oncology drug supply process.
Provide the medicine name, required strength, formulation, quantity and destination country through our enquiry form. Our team can then review current sourcing options, documentation requirements, pricing and procurement timelines.
